期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

代谢性危险因素与病毒性肝炎 被引量：2

下载PDF
导出
摘要 代谢性危险因素包括中心性肥胖、肝脂肪变性、胰岛素抵抗、2型糖尿病和代谢综合征。慢性乙型肝炎和慢性丙型肝炎是两种常见的慢性肝病。近年来发现它们合并代谢综合征的病例越来越多。本文将对代谢性危险因素与病毒性肝炎的关系作一简要介绍。
作者 段晓燕 范建高
机构地区 上海交通大学医学院附属第一人民医院脂肪肝诊治中心 上海交通大学医学院附属新华医院消化内科
出处 《实用肝脏病杂志》 CAS 2009年第6期462-467,共6页 Journal of Practical Hepatology
关键词 乙型肝炎 丙型肝炎 代谢性 危险因素
分类号 R512.6 [医药卫生—内科学] R589.6 [医药卫生—内分泌]
  • 相关文献

参考文献3

二级参考文献32

  • 1Teli MR,James OF,Burt AD.The natural history of nonalcoholic fatty liver disease.Hepatology 1994;22:1714-1719.
  • 2Caldwell S,Oelsner D,Iezzoni J,Hespenheide E,Battle E,Driscoll C. Cryptogenic cirrhosis:clinical characterization and risk factors for underlying disease.Hepatology 1999;29:664-669.
  • 3George D,Goldwurm S,MacDonald G,Cowley LL,Walker NI,Ward PJ, Jazwinska EC,Powell LW.Increased hepaticir on concentration in nonalcoholic steatohepatitis is associated with incresad fihrcosis. Gstroenterology 1998,114:311-318.
  • 4Schiff ER,Sorell MF,Maddrey WC.Disease of the Liver.6 th ed. Philedelphia:Lippincot- Williams and Wilkins,1999:1185-1197.
  • 5Adinolfi LE,Gambardella M,Andreana A,Tripodi MF,Utili R,Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.Hepatology 2001;33:1358-1364.
  • 6Hourigan LF,Macdonald GA,Purdie D,Whitehall VH,Shorthouse C, Clouston A,Powell EE.Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis.Hepatology 1999; 29:1215-1219.
  • 7Westin J,Nordlinger H,Lagging M,Norkans G,Wejstal R.Steatosis accelaerates fibrosis development over time in hepatitis C virus genotype 3 infected patients.J Hepatol 2002;37:837-842.
  • 8Castera L,Hezode C,Roudot-Thoraval F,Bastie A,Zafrani ES,Patlowsky JM,Dhumeaux D.Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.Gut 2003;52:288-292.
  • 9Phillips MJ,Cameron R,Flowers MA,Blendis LM,Greig PD,Wanless I, Sherman M,Superina R,Langer B,Levy GA.Posttransplant recurrent hepatitis B viral liver disease.Viral-burden,steatoviral,and fibroviral hepatitis B.Am J Pathol 1992;140:1295-1308.
  • 10Matsumaru K,Ishii K,Shinora M,Sumino Y,Aikawa A,Hasegava A,Nonaka H, Akima M.A renal allograft recipientwith viral-burden,steatoviral, and fibroviral hepatitis B who achieved remission with lamuvidine.J Clin Gastroenterol 2003;36:187-188.

共引文献109

同被引文献13

  • 1范建高.糖尿病与肝病的关系及其诊治对策[J].中华糖尿病杂志,2009,1(4). 被引量：30
  • 2范建高,贾继东.脂肪性肝病诊疗进展[M].北京:人民卫生出版社,2009:79-87.
  • 3FAN JG,FARRELL GC. Epidemiology of non-alcoholic fatty liver disease in China [J]. J Hepatol,2009,50(1): 204-210.
  • 4VUPPALANCHI R,CHALASANI N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis:selected practical issues in their evaluation and management[J]. Hepatology, 2009,49 (2) : 306-317.
  • 5ALI R,CUSI K. New diagnostic and treatment approaches in non-alcoholic fatty liver disease ( NAFLD )[J]. Ann Med, 2009,41 (2) : 265-278.
  • 6FAN JG,FARRELL GC. Prevention of hepatocellular carcinoma in non-viral related liver diseases [J]. J Gastroenterol Hepatol, 2009,24 (5) : 712-719.
  • 7LOOMBA R,SIRLIN CB,SCHWIMMER JB,et al. Advances in pediatric nonalcoholic fatty liver disease [J]. Hepatology,2009,50(4) : 1282-1293.
  • 8RILEY P,AL BAKIR M,O'DONOHUE J,et al. Prescribing statins to patients with nonalcoholic fatty liver disease:real cardiovascular benefits outweigh theoretical hepatotoxic risk [J]. Cardiovasc Ther,2009,27 (2):215- 220.
  • 9张见芬.脂肪肝CT诊断与血脂代谢关系分析[J].临床心身疾病杂志,2014,20(增刊):128.
  • 10Riley P, A1 Bakir M, O'Donohue J, et al. Prescribing statins to patients with nonalcoholic fatty liver disease: real cardiovascular benefits outweigh theoretical hepatotoxic risk [J]. Cardiovasc Ther, 2009, 27(3): 216.

引证文献2

二级引证文献31

实用肝脏病杂志
2009年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部